Latest / Cleveland Clinic Cancer Advances
FDA Approved: Lutetium-PSMA for Metastatic Prostate Cancer
Christopher Wee, MD, a medical oncologist from the Genitourinary Medical Oncology Program at Taussig Cancer Institute joins the Cancer Advances podcast to talk about therapies for metastatic prostate cancer. Listen as Dr. Wee discusses Lutetium-PSMA and the clinical trials that showed patients had better response rates and fewer toxicities when they got lutetium on top of their care.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.